Peptides & Cancer — The Dangerous Ones You Must Avoid | Dr. Dino Prato

Dr. Prato explores the promising field of peptide therapy, highlighting how these powerful compounds can contribute to healthy aging and overall wellness.We discuss the potential for peptides to support joint health and bone health, offering a new perspective on maintaining physical vitality. The research also suggests benefits for brain health, making peptides a fascinating area of study for those interested in anti-aging strategies.🎯 What You’ll Learn in This Episode:- What peptides actually are- Why timing matters during chemotherapy- Which peptides may stimulate growth pathways- Which peptides may support immune signaling- The risks of black-market peptide sourcing- Why diet, sleep, and gut health come first- How precision oncology integrates immune support safely- The importance of physician supervision📍 Envita Medical Centers – Scottsdale, AZ🌐 Learn more: www.envita.com📞 Speak with a care coordinator: 866-830-4576“Peptides don’t heal chaos — they amplify signals. Make sure the signal is the right one.”Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.________________________________________Outcomes DisclaimerThe results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493